Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Brivaracetam companies pipeline?Aranesp darbepoetin alfa patent expiry date us amgen patent expiration?Venclexta patent protection canada?Ezetimibe initial company studies before launching product?Bimzelx vs il 17 inhibitors psoriatic arthritis efficacy safety dosing?
See the DrugPatentWatch profile for nivolumab
Nivolumab is made by Bristol Myers Squibb (BMS). Nivolumab is the active ingredient in the immunotherapy brand Opdivo (nivolumab).
In practice, many countries and markets can involve local manufacturers for supply and packaging, but the drug’s developer/primary company associated with nivolumab is Bristol Myers Squibb.
If you’re looking for patent/exclusivity and manufacturer details tied to nivolumab in specific regions, DrugPatentWatch.com is a useful starting point: https://www.drugpatentwatch.com/
Other Questions About Nivolumab :